Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1237210
Max Phase: Preclinical
Molecular Formula: C35H52O4
Molecular Weight: 536.80
Molecule Type: Small molecule
Associated Items:
ID: ALA1237210
Max Phase: Preclinical
Molecular Formula: C35H52O4
Molecular Weight: 536.80
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)=CCC1=C(O)[C@@]2(C(=O)C(C)C)C(=O)[C@](CC=C(C)C)(C[C@H](CC=C(C)C)[C@@]2(C)CCC=C(C)C)C1=O
Standard InChI: InChI=1S/C35H52O4/c1-22(2)13-12-19-33(11)27(16-14-23(3)4)21-34(20-18-25(7)8)30(37)28(17-15-24(5)6)31(38)35(33,32(34)39)29(36)26(9)10/h13-15,18,26-27,38H,12,16-17,19-21H2,1-11H3/t27-,33+,34+,35-/m0/s1
Standard InChI Key: IWBJJCOKGLUQIZ-HQKKAZOISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 536.80 | Molecular Weight (Monoisotopic): 536.3866 | AlogP: 8.99 | #Rotatable Bonds: 11 |
Polar Surface Area: 71.44 | Molecular Species: ACID | HBA: 4 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 3.82 | CX Basic pKa: | CX LogP: 9.67 | CX LogD: 6.41 |
Aromatic Rings: 0 | Heavy Atoms: 39 | QED Weighted: 0.21 | Np Likeness Score: 2.52 |
1. Kumar A, Chauhan S.. (2016) How much successful are the medicinal chemists in modulation of SIRT1: A critical review., 119 [PMID:27153347] [10.1016/j.ejmech.2016.04.063] |
2. Gao W, Hou WZ, Zhao J, Xu F, Li L, Xu F, Sun H, Xing JG, Peng Y, Wang XL, Ji TF, Gu ZY.. (2016) Polycyclic Polyprenylated Acylphloroglucinol Congeners from Hypericum scabrum., 79 (6): [PMID:27280968] [10.1021/acs.jnatprod.5b01063] |
3. Cottet K, Xu B, Coric P, Bouaziz S, Michel S, Vidal M, Lallemand MC, Broussy S.. (2016) Guttiferone A Aggregates Modulate Silent Information Regulator 1 (SIRT1) Activity., 59 (20): [PMID:27669815] [10.1021/acs.jmedchem.6b01182] |
4. Khan H, Rengasamy KRR, Pervaiz A, Nabavi SM, Atanasov AG, Kamal MA.. (2018) Plant-derived mPGES-1 inhibitors or suppressors: A new emerging trend in the search for small molecules to combat inflammation., 153 [PMID:29329790] [10.1016/j.ejmech.2017.12.059] |
5. Hall A, Chanteux H, Ménochet K, Ledecq M, Schulze MED.. (2021) Designing Out PXR Activity on Drug Discovery Projects: A Review of Structure-Based Methods, Empirical and Computational Approaches., 64 (10.0): [PMID:34003642] [10.1021/acs.jmedchem.0c02245] |
Source(1):